In the study, treatment with AGA111, a recombinant human bone morphogenetic protein 6 (rhBMP6), led to faster radiographic fusion and a higher fusion success rate, as well as greater improvements in ...

The patient was a 73-year-old man with progressively disabling right hip pain for 2.5 years. The patient had failed ...

The Department for Work and Pensions' upcoming plans for Universal Credit and Personal Independence Payment (PIP) have been ...

The Department for Work and Pensions plans for Universal Credit and Personal Independence Payment (PIP) by the end of the month have been branded "frightening". Labour Party MP Richard Burgon has led ...

Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...

Patients suffering from debilitating spine problems now have a leading expert to turn to-Dr. Michael R. Wheeler, MD, a distinguished spi ...

Aurora Spine completed enrollment for its Refine study on lumbar interlaminar fusion, according to a March 10 news release.

Discure Technologies, a clinical-stage medical device company pioneering treatments for degenerative disc disease and other orthopedic disorders, today announced its acceptance into the U.S. Food and ...

Spinal Stabilization Technologies enrolled its first U.S. patient in the Investigational Device Exemption clinical trial for its PerQdisc Nucleus Replacement Device.

Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. patient in its Investigational Device ...